Aim: This study was aimed to investigate the hemocompatibility of zirconia and titanium implant materials after surface treatment with sandblasting and acid etching (SLA).
INTRODUCTION
The most widely acceptable and predictable treatment modality from past 30 years, for partial and fully edentulous patients,is the use of dental implants endosseous anchored directly with the bone-to-implant contact in the jaws.By following certain surgical principles, direct implant anchorage with bone can be achieved as shown in a few studies. This implant anchorage modality is termed often as functional ankylosis or osseointegration.
Nowadays the necessity for implant supported longduration prosthetic treatment is increasing in dental practice. The significant implant failure associated with the treatments holds as a drawback to resort to the treatment again. The experimental procedures that have been successfully used to improve the bone integration of dental implants have been limited to variations in design and to surface treatments. 2 The implantation period for the induction of the bone using porous bioactive titanium is about 12 months which is longer compared to that of porous calciumphosphate based biomaterials of 45 to 90 days.
3 the implant's success rate depends on its biocompatibility and osseointegration. 4 Biocompatibility may be divided into hemocompatibility (blood) and cytocompatibility (cell and tissue). The biocompatibility depends on the survival of the cell affected by the material usage. The cascade of events occurred by the molecular interference with macromolecular synthesis, which causes unequivocal cellular, structural and functional damage is described as 'cytotoxicity'. 5 Hemocompatibility is a prerequisite for materials used in biomedical products like cardiovascular implants, catheters and medical membranes as otherwise surface initiated coagulation processes and immune reactions occur. This interaction can destruct or activate the blood components. Blood is a complex tissue consists of cells and plasma. Blood plasma is an electrolytic isotonic solution, consisting of sodium chloride of 0.9% with high protein content relatively 40-60 g/L. Albumin makes more than half of total plasma proteins, but many low level constituents are critical for the function of whole organism e.g. transporter proteins, clotting factors, antiproteases, or immunoglobulins. 6 The surface property of a titanium implant is largely determined by a thin oxide film covered as a protective layer. 7 there are no such studies to prove the hemocompatibility of the zirconia and the effect of surface treatment on it, as it is a newly introduced implant material. And there is no available literature with a combination of 20% HCL acid etchant and 150 microns (average particle size). So this study was conducted to investigate hemocompatibility of commercially available materials (zirconia and titanium) after sandblasting and acid etching (SLA).
MATERIALS AND METHODS
The present in vitro study was conducted in the Department of Prosthodontics, Coorg Institute of Dental Sciences, Virajpet.
Sample Size
Thirty specimens (10 mm × 3 mm) each of both titanium and zirconia disks were categorized under 2 groups (A and B). Group A and B were subdivided as 1 and 2, wherein smooth polish disks were categorized under 1 and sand blasted with acid etched (SLA) disks were categorized under 2.
• Group A 1 : Smoothly polished titanium disks (Fig. 1 
Procedure
Thirty specimens of Grade 5 titanium (Ti-6Al-4V), prefabricated medical grade with 10mm x 3mm dimension and thirty specimens of the same dimension of sintered zirconia were procured from manufacturers. The specimen surfaces were polished using grit papers of silicon carbide (240 to 1200 µm) and later washed with water to remove any particles created while polishing. Using distilled water, ultrasonic cleaning was done for 5 minutes. Fifteen specimens each from titanium (Group A1) and zirconia (Group B1) were used as control specimens. The remaining titanium (Group A2) and zirconia (Group B2) were subjected to surface treatments.
SLA Treatment of Specimens
Sandblasting (Fig. 3) Fifteen specimens of both titanium (Group A2) and zirconia (Group B2) were placed inside the sandblasting A B machine at a standard distance of 10 mm from the nozzle and sandblasted using alumina (average particle size 150 microns) for 10 seconds. The sandblasted specimens were washed for 30 seconds using an ultrasonic cleaner to eliminate any remaining alumina particles.
Acid etching
The specimens were kept in a petri dish for 10 seconds, under 20% dilute solutions of hydrochloric acid, subjecting to acid etch. The specimens were washed again placing under ultrasonic cleaner to eliminate the remaining solution for 30 seconds.
Scanning Electron Microscopy
The test specimens were analyzed for surface characteristics after surface treatment using a scanning electron microscope (SEM) for evaluation purpose. Using the mounting plate, all the specimens were mounted and for analysis purpose, they were loaded on the SEM machine. For cleaning the surface, the specimens were sprayed with 90% ethanol. Afterward, a vacuum is created inside the chamber. To focus the lens inside the SEM machine exactly at the center of the specimen, the camera inside the chamber is used. All the specimen's images were recorded at 3000x magnification (Figs 4 and 5).
Exposure of Materials to Blood
Volunteer healthy adult human's blood was collected in the collection tube (total of 60 ml) with anticoagulant [sodium citrate, Ethylenediaminetetraacetic acid (EDTA)] and for the uniform mix of blood with the coagulant, thecollection tube is kept for 10 minutes on blood roller. Before exposing blood to specimens, leucocyte and platelet count were recorded. Both group specimens were agitated for 5 minutes with phosphate buffer saline to clean the surface before exposing it to blood. All the specimens from each group were kept in separate petri dishes. About 1 ml of blood from the collection tube was added to the specimens kept in the Petri dish for 30 minutes.
Analysis of Blood Parameter (Fig. 6)
"Automated hematology analyzer" was used to record the leucocyte and platelet count, before and after exposing specimens to blood for 30 minutes. 
Percentage Hemolysis
The platelet count after and before the exposure of blood to specimens was calculated and the change in the count was noted.
Thrombin time (TT) and Prothrombin time (PT) measurement
Using centrifugation method at 3000 rpm for 15 minutes, the platelet-rich plasma was separated from the blood stored in anticoagulant (sodium citrate) collected in collection tube collected from the same volunteer. The supernatant 2 mLof platelet poor plasma was kept in contact with the test specimens for 10 minutes at a temperature of 37° C kept in a petri dish inside an incubator. The measurements of PT and TT were performed by adding respective PT and TT reagents into the test tube containing 200 mL of platelet poor plasma and clotting time were evaluated.
Platelet Adhesion and Activation
Before the exposure of the specimens to the blood, leucocyte count was noted. Specimens were later exposed to the blood in the test tube containing anticoagulant (sodium citrate). After 30 minutes of exposure, the leukocyte count is calculated. The before and after difference in the leukocyte count of the blood exposed specimens will be directly proportional to the number of lysed cells.
Data Analysis
The statistical analysis was done using t-test and the values were obtained form all the groups followed by p-values.
RESULTS
The results from Table 1 shows the control group values before exposure of specimens to the blood; the platelet count was 188 x 10 3 /µL, leucocyte count was 7.4 x 10 3 /µL, prothrombin time value was 12 seconds and thrombin time value was 13 seconds.
The comparative difference values in the mean platelet count before and after the specimen exposure to blood has been revealed in Table 2 . A 1 (polished titanium) has shown the highest mean value of 184.67 ± 1.29 after exposure, followed by A 2 (SLA treated titanium) with 183.40 ± 2.74, B 2 (SLA treated zirconia) with 182.20 ± 2.75 and least was seen in B 1 (polished zirconia) with 182.13 ± 2.23 specimens. Table 3 describes the leucocyte count after the specimen exposure to blood. The highest mean value was seen in A 1 (polished titanium) with 7.27 ± 0.08, followed by A 2 (SLA treated titanium) with 7.23 ± 0.07 and least was seen in both B 1 (polished zirconia) and B 2 (SLA treated zirconia) with same mean of 7.22 ± 0.07.
The prothrombin value after the specimen exposure to blood as shown in Table 4 , was highest in A 2 (SLA treated titanium) with the highest mean of 10.04 ± 0.24, followed by A 1 (polished titanium) with 9.97 ± 0.26, B 2 (SLA treated zirconia) with 9.90 ± 0.29 and least was seen in B 1 (polished zirconia) with 9.88 ± 0.32. Table 5 describes the thrombin time after the specimen exposure to blood. The highest mean value was seen in A 1 (polished titanium) with 10.15 ± 0.34, followed by A 2 (SLA treated titanium) with 10.006 ± 0.41), B 2 (SLA treated zirconia) with 10.00 ± 0.25 and least was seen in B 1 (polished zirconia) with 9.95 ± 0.32.
The SEM image shows (Figs 2 and 4 ) that the SLA treated titanium and zirconia has more surface roughness followed by sand blasted and untreated titanium, zirconia specimens.
DISCUSSION
Protein adsorption is the first event which occurs when blood contacts any artificial surface. The denaturing of the adsorbed protein such as fibrinogen activates the platelet or the coagulation factors causing blood coagulation cascade reaction. Formation of thrombosis is the final step. The effective blood-compatible material should help in prohibiting the adsorption of globulin or fibrinogen, which are known as harmful protein on the material surface and to be favorable for albumin (good protein) to adsorb on the surface. Secondly, the protein adsorption to the artificial surface can be prevented from becoming denatured. The fibrinogen denaturation has been proved to be related to the transfer of charges from fibrinogen to the material and the decomposition of the fibrinogen into fibrin peptides and fibrin monomer. 8 To test the thrombogenicity, a most commonly in-vivo method is used. For the unsuited devices to this first method, ISO 10993-4 requires tests to be conducted in four categories each: hematology, coagulation, complements system, and platelets. Testing the complement activation is most recommended for implant devices that contact the circulatory blood. This in-vitro assay measures the human plasma complement activation indicating the plasma exposure to the Materials used in this study are titanium and zirconia. The study conducted by Gahlert et al. 9 have used the same implant materials (titanium and zirconia), to study the osseointegration. Titanium materials are commonly used because of its well-documented beneficial results, favorable mechanical properties, and excellent biocompatibility. Microscale roughness of zirconia is more preferred than the conventional surfaces, such as machined surfaces. Titanium with micro-roughened surfaces can be attained by the process of particle blasting, Ti plasma spraying, machining, chemical/ electrochemical etching, or particle blasting and by chemical etching. One of the most versatile instruments used to examine and to analyze the morphological microstructure and characterization of chemical composition is scanning electron microscope. To evaluate the surface characteristics before the surface treatment and after the surface treatment, the specimens were analyzed under a scanning electron microscope (SEM). Through SEM images, it was proved that the Ti and Zr after SLA treatment have a rougher surface. This indicates that there is an increase in the surface area for osseointegration, with an increase in the bone to implant surface ratio which leads to the success of the implant.
An in vitro study was conducted by Bhavanchand et al. 4 to evaluate the titanium's hemocompatibility after surface treatment. The hemocompatibility test showed a reduction in the platelet count, but was under ISO standards, after exposing to titanium samples. It was concluded that hemocompatibility does not vary in medical grade titanium after different surface modification. The increase in the surface roughness was observed, which increased the implant to bone ratio. Similar results were seen in the present study in both titanium and zirconia polished and SLA treated implant materials.
The present study showed that there were increased surface irregularities in SLA treated titanium compared to that of polished titanium from the SEM image. These results were similar to the biocompatibility study conducted by Kim et al. 10 on SLA treated implants of titanium. The surface of the titanium implants was sandblasted (using large grits) and acid etched (SLA). It increased the surface of the implants for osseointegration. The topographic surface of the titanium was scanned for investigation with a profilometer and SEM. A small uniform micro pits measuring 1 to 2 µm diameter were demonstrated on SLA treated implants. The average roughness (Ra) was 1.19 µm with a maximum height (Rt) of 10.53 µm after SLA. The study on titanium osteoinductive porous implants was conducted by Takemoto et.al. 3 The diluted HCL treatment gave topographic (etching) and chemical (titania formation and sodium removal) effects on the surface of the titanium, though predominant factor cannot be determined. In the present study, surface treatment was done with 20% HCL on zirconia and titanium after sandblasting using alumina particles (150 microns). From the above study, it can be suggested that osteoinductivity will be better after the surface treatment. Thrombogenicity depends on the relative adsorption of plasma proteins such as albumin and fibrinogen to the surface as suggested by the study conducted by Packham 11 and Kang et al. 12 The blood clot formation is mediated by fibrinogen (factor I) glycoprotein.
To access the hemocompatibility between the materials and arterial blood flow, Sanak et al 6 conducted a study. The hemocompatibility test for medical materials to detect the interaction between the blood material and artificial surface, to notice the adverse reaction, which can destruct or activate the blood component. The in vitro study conducted by Schreiber et.al 13 on surface modified dental implants showed that titanium nitride (TiN) coated on titanium implant material decreased the colonization of the bacteria compared to other clinically used implant surfaces. The surface of the titanium material which has an antimicrobial role is also examined for the support of fibroblast growth within a TiN surface. The study on the zirconia implant's osseointegration was conducted by Depprich et.al 14 , a bone to implant interface was done through SEM observation. The observation showed the bone attachment seen already after a week, which is remarkable and increased further for intimate contact with the bone after 4 weeks, which is observed on the implant surfaces of both titanium and zirconia. Osseointegration was seen after 12 weeks, without the interposition of an interfacial layer. A study was conducted by Li et al. 15 to know the effect of hydrofluoric acid treatment on osseointegration of titanium implant. The results showed improvement in the osseointegration of titanium implant proved the effectiveness of the HF treatment on Ti surface. An in-vivo study to know the zirconia surface characteristics of the implant material was conducted by Zinelis et.al. 16 Differences were found between the implants which are in the monoclinic to tetragonal ZrO 2 phase transformation,extent of contamination of carbon, residual alumina content, and 3D-roughness parameters contributing to a substantial differentiation in the tissue and cellular response in bone. Currently, there were no available studies on zirconia hemocompatibility after surface treatment with SLA. Therefore, the present study was conducted to know the zirconia's hemocompatibility after surface treatment with SLA. The SEM imaging showed an increase in the surface irregularities in SLA treated specimens when compared to polished zirconia and titanium specimens. Before and after the surface treatment, both implant materials (titanium and zirconia) showed hemocompatibility. The maximum hemocompatibility was seen with polished titanium compared to other groups.
CONCLUSION
In conclusion, surface treatment with sandblasting and acid etching (SLA) using 150 microns alumina particles and 20% hydrochloric acid increased the
